| Q36747329 | A choline derivate-modified nanoprobe for glioma diagnosis using MRI. |
| Q33261465 | A direct method for measuring mouse capillary cortical blood volume using multiphoton laser scanning microscopy. |
| Q92257741 | ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas |
| Q34000631 | Advances in strategies to improve drug delivery to brain tumors |
| Q34728592 | Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively |
| Q28131675 | Astrocyte-endothelial interactions at the blood-brain barrier |
| Q59793802 | Benchmarking in vitro tissue-engineered blood-brain barrier models |
| Q44916496 | Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses |
| Q36118847 | Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone |
| Q28973613 | Biological and medical applications of a brain-on-a-chip |
| Q59128234 | Block Face Scanning Electron Microscopy of Fluorescently Labeled Axons Without Using Near Infra-Red Branding |
| Q30436341 | Blood brain barrier: the role of calcium homeostasis. |
| Q36202424 | Blood glutamate scavenging: insight into neuroprotection |
| Q26829741 | Brain tumor-targeted drug delivery strategies |
| Q89575010 | Brain-wide glymphatic enhancement and clearance in humans assessed with MRI |
| Q37714988 | Chapter 3 - Colloidal systems for CNS drug delivery |
| Q30930526 | Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors |
| Q42785240 | Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery |
| Q30564565 | Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q36478643 | Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas |
| Q37149169 | Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels. |
| Q33829590 | Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study |
| Q34143913 | Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells |
| Q38259307 | Delivery of therapeutic peptides and proteins to the CNS. |
| Q45119931 | Differences in the molecular structure of the blood-brain barrier in the cerebral cortex and white matter: an in silico, in vitro, and ex vivo study. |
| Q37299061 | Diffusion in brain extracellular space. |
| Q36823757 | Diffusion of macromolecules in the brain: implications for drug delivery |
| Q37362486 | Drug interactions at the blood-brain barrier: fact or fantasy? |
| Q37141956 | Dynamic model for the tissue concentration and oxygen saturation of hemoglobin in relation to blood volume, flow velocity, and oxygen consumption: Implications for functional neuroimaging and coherent hemodynamics spectroscopy (CHS). |
| Q40089704 | EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise. |
| Q37091154 | Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells |
| Q37991010 | Efflux transporters in the blood-brain interfaces--in vitro and in vivo methods and correlations |
| Q90706949 | Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours |
| Q47163222 | Engineering the human blood-brain barrier in vitro |
| Q93036983 | Enhanced neuronal activity in mouse motor cortex with microbubbles' oscillations by transcranial focused ultrasound stimulation |
| Q39092142 | Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria. |
| Q24630696 | Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network |
| Q33634475 | Fatty acids in energy metabolism of the central nervous system |
| Q36812384 | Heterogeneity of the blood-brain barrier |
| Q47119481 | Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation |
| Q35800491 | How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging |
| Q58573409 | Immune Checkpoints and Innovative Therapies in Glioblastoma |
| Q48419354 | Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model |
| Q34955005 | Intraoperative infrared imaging of brain tumors |
| Q39135724 | Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma |
| Q34048921 | Lack of angiogenesis in experimental brain metastases |
| Q42854557 | Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma Rats |
| Q48761555 | MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis |
| Q36528148 | Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo |
| Q47843849 | Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment |
| Q35560495 | Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence |
| Q47142132 | MicroRNA in Glioblastoma: An Overview |
| Q33271099 | Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels |
| Q35108066 | Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3) |
| Q36812347 | Nanoparticle transport across the blood brain barrier. |
| Q28394053 | Nanoparticles for imaging and treating brain cancer |
| Q41992016 | Nanoscale effects in dendrimer-mediated targeting of neuroinflammation |
| Q37939942 | Nanostructure-based drug delivery systems for brain targeting. |
| Q38133407 | Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors |
| Q97525213 | PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis |
| Q57790000 | Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches |
| Q37602559 | Permeability across a novel microfluidic blood-tumor barrier model |
| Q21245468 | Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors |
| Q37076360 | Polymeric nanoparticles for the drug delivery to the central nervous system |
| Q38011262 | Recent advances in brain tumor-targeted nano-drug delivery systems |
| Q37346039 | Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors |
| Q41229885 | Remodeling the blood-brain barrier microenvironment by natural products for brain tumor therapy |
| Q30438834 | Role of cholinergic system and calcium synchronization in schizophrenia |
| Q92862254 | Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance |
| Q28743361 | Scaling of brain metabolism and blood flow in relation to capillary and neural scaling |
| Q36390455 | Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. |
| Q55463476 | Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy. |
| Q30402051 | Sonogenetics is a non-invasive approach to activating neurons in Caenorhabditis elegans |
| Q47227963 | Spatio-temporal dynamics of cerebral capillary segments with stalling red blood cells. |
| Q34585071 | Strategies for increasing drug delivery to the brain: focus on brain lymphoma |
| Q38937398 | Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases |
| Q38791884 | Targeted brain delivery nanoparticles for malignant gliomas. |
| Q27010580 | Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide |
| Q35762072 | Targeted delivery of proteins across the blood-brain barrier |
| Q26738886 | Targeting blood-brain-barrier transcytosis - perspectives for drug delivery |
| Q38791773 | Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation |
| Q38134725 | The blood-brain barrier: an engineering perspective. |
| Q38232202 | The blood-brain barrier: structure, function and therapeutic approaches to cross it. |
| Q91677833 | The impact of endothelial cell death in the brain and its role after stroke: A systematic review |
| Q64053507 | The need for mathematical modelling of spatial drug distribution within the brain |
| Q43565983 | The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis |
| Q35546851 | The vascular network of tumours — what is it not for? |
| Q42013193 | Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors |
| Q36812411 | Tight junction modulation of the blood brain barrier: CNS delivery of small molecules |
| Q41867160 | Towards MR-navigable Nanorobotic Carriers for Drug Delivery into the Brain. |
| Q36408061 | Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability |
| Q61449202 | Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges |
| Q38106370 | Update on bevacizumab and other angiogenesis inhibitors for brain cancer |
| Q46965926 | VEGF immunopositivity related to malignancy degree, proliferative activity and angiogenesis in ENU-induced gliomas |
| Q30638278 | Vascular microenvironment in gliomas |
| Q48452559 | Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: theoretical analysis |